
    
      For patients having exudative ARMD with CNV, whose vascular structures are clearly
      demonstrated in ICGA , ranibizumab is injected monthly three times, then pro re nata to 6
      months. Vascular structures of CNV is investigated at baseline, 3 and 6 months using ICGA.
      Expected number of patients are 48 eyes from 4 centers, competitively.
    
  